Some patients have increased symptoms after SSRI discontinuation, but most do well.
Patients with dementia, even those who do not have major depression, are often treated with antidepressants and remain on them long-term, although efficacy is unclear. To address this issue, researchers used a unique design: They included 128 patients with dementia but not with clinical depression who were treated with selective serotonin reuptake inhibitors (SSRIs; most likely prescribed for problems with mood and behavior), randomly assigned half to discontinuation, and examined depressive and neuropsychiatric symptoms up to 25 weeks later. For discontinuers, antidepressants were tapered off in the first week after assessment. The mean age was 86, and most were women (discontinuation group, 78%; continuation group, 72%).
After 25 weeks, th…
Reviewing Author
DisclosuresRoyaltiesTextbook of Traumatic Brain Injury, 2nd and 3rd editions
Editorial BoardsUpToDate; Journal of Neuropsychiatry and Clinical Neuroscience
Leadership Positions in Professional SocietiesNorth American Brain Injury Association (Board Member); National Institute on Disability, Independent Living, and Rehabilitation Research (Chair of Data Monitoring Safety Board for study of donepezil on cognition after traumatic brain injury)
DisclosuresRoyaltiesTextbook of Traumatic Brain Injury, 2nd and 3rd editions
Editorial BoardsUpToDate; Journal of Neuropsychiatry and Clinical Neuroscience
Leadership Positions in Professional SocietiesNorth American Brain Injury Association (Board Member); National Institute on Disability, Independent Living, and Rehabilitation Research (Chair of Data Monitoring Safety Board for study of donepezil on cognition after traumatic brain injury)